SP140L is a primate-specific chr2 reader and herpesvirus restriction factor that functions as a transcriptional regulator and innate immune sentinel. As a member of the Speckled Protein family, SP140L contains functional domains (SAND, PHD, bromodomain) that interact with DNA and modified histones 1, enabling DNA-binding transcription factor activity in the nucleus 1. Mechanistically, SP140L suppresses viral transcription and activates interferon-stimulated genes, linking DNA sensing and transcriptional suppression of viral DNA to an interferon-independent innate immune response 23. The protein serves as a restriction factor against diverse nuclear DNA viruses, including Epstein-Barr virus and herpesvirus saimiri, which encode antagonistic viral proteins (EBNA-LP and ORF3) to disrupt SP140L function and establish latent infection 24. Beyond viral immunity, SP140L is implicated in autoimmune disease pathogenesis; it is a recognized target of anti-Mi2 autoantibodies in myositis patients 5 and functions as a crosstalk gene in Primary Sjögren's Syndrome and Primary Biliary Cirrhosis 6. In cancer, SP140L shows context-dependent roles, particularly correlating with poor prognosis in pancreatic adenocarcinoma 7, while being identified as a negative biomarker associated with treatment resistance in HER2+ breast cancer 8.